Glycopyrrolate Tablets Approved

Boca Pharmacal has received approval from the FDA to market Glycopyrrolate Tablets USP, 1mg and 2mg, the generic version of Shionogi Pharma's Robinul Tablets, 1mg and Robinul Forte Tablets, 2mg.

Glycopyrrolate tablets are intended for use as adjunctive therapy in the treatment of peptic ulcers.

For more information visit www.bocapharmacal.com.